Value of ~(18)F-FDGhPET/CT imaging in the diagnosis and staging of non-small cell lung cancer
Zhang Li-ping
Abstract
Zhang Li-ping
Abstract
Objective To study the value of 18F-FDGhPET/CT imaging for diagnosis,staging,limiting the tumor target region and determining treatment principle in non-small cell lung cancer.Methods Fifty-three patients with non-small cell lung cancer were examined by 18F-FDGhPET/CT imaging before the treatment to study and compare 18F-FDG staging and CT staging.Results 18F-FDGhPET/CT imaging detected 39 lymph nodes and 22 distant metastases more than CT imaging did.Clinical staging of 28 patients was changed by 18F-FDGhPET/CT,including upgrade of staging in 20 cases and degradation of staging in 8 cases.Conclusion 18F-FDGhPET/CT imaging is useful for diagnosis,staging,radiotherapy treatment plan and guiding general therapy principle of NSCLC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the value of 18F-FDGhPET/CT imaging for diagnosis,staging,limiting the tumor target region and determining treatment principle in non-small cell lung cancer.Methods Fifty-three patients with non-small cell lung cancer were examined by 18F-FDGhPET/CT imaging before the treatment to study and compare 18F-FDG staging and CT staging.Results 18F-FDGhPET/CT imaging detected 39 lymph nodes and 22 distant metastases more than CT imaging did.Clinical staging of 28 patients was changed by 18F-FDGhPET/CT,including upgrade of staging in 20 cases and degradation of staging in 8 cases.Conclusion 18F-FDGhPET/CT imaging is useful for diagnosis,staging,radiotherapy treatment plan and guiding general therapy principle of NSCLC.
Key concepts: Medicine, Radiology, Lung cancer, Radiation therapy, Radiation treatment planning, Lymph, Nuclear medicine, Oncology